Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lipodel
2. Liponet
3. Obliterol
4. Pantethine, (d)-(+)-isomer
5. Pantethine, 14c-labeled Cpd
1. D-pantethine
2. 16816-67-4
3. Pantomin
4. Pantetina
5. Pantosin
6. Lbf Disulfide
7. Pantethine [jan]
8. Bis(pantothenamidoethyl) Disulfide
9. D-pantethine Syrup
10. D-bis(n-pantothenyl-beta-aminoethyl) Disulfide
11. (2r)-n-[3-[2-[2-[3-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyldisulfanyl]ethylamino]-3-oxopropyl]-2,4-dihydroxy-3,3-dimethylbutanamide
12. D-bis(n-pantothenyl-2-aminoethyl)-disulfide
13. Lipodel
14. Chebi:31959
15. 7k81il792l
16. Nsc-759269
17. (r-(r*,r*))-n,n'-(dithiobis(ethyleneimino(3-oxopropane-3,1-diyl)))bis(2,4-dihydroxy-3,3-dimethylbutyramide)
18. 644967-47-5
19. Pantosin (tn)
20. (2r)-n-[2-({2-[(2-{3-[(2r)-2,4-dihydroxy-3,3-dimethylbutanamido]propanamido}ethyl)disulfanyl]ethyl}carbamoyl)ethyl]-2,4-dihydroxy-3,3-dimethylbutanamide
21. (2r,2'r)-n,n'-(((disulfanediylbis(ethane-2,1-diyl))bis(azanediyl))bis(3-oxopropane-3,1-diyl))bis(2,4-dihydroxy-3,3-dimethylbutanamide)
22. Butanamide, N,n'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethyl-, (2r,2'r)-
23. Butanamide, N,n'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethyl-, (2r,2'r)-rel-
24. Einecs 240-842-8
25. Bis-pantethine
26. Unii-7k81il792l
27. D-pantomin
28. Pantethine Liquid
29. Ncgc00181028-01
30. Pantethine 50 G
31. Pantethine 80%
32. Butanamide, N,n'-(dithiobis(2,1-ethanediylimino(3-oxo-3,1-propanediyl)))bis(2,4-dihydroxy-3,3-dimethyl-, (2r,2'r)-
33. Pantethine [mi]
34. Pantethine 50% Granule
35. Pantethine [inci]
36. Pantethine(50% Granula)
37. Pantethine [mart.]
38. D-pantethine Hydrate, Syrup
39. Pantethine [who-dd]
40. Mls004734407
41. Schembl1650348
42. Chembl2104786
43. Dtxsid9046815
44. D-pantethine, Analytical Standard
45. Hy-b1028
46. Zinc3874604
47. Mfcd07357234
48. S5220
49. Akos015898599
50. Ccg-270026
51. Cs-4546
52. Db11190
53. Gs-6223
54. Nsc 759269
55. Ncgc00181028-02
56. Butanamide, N,n'-(dithiobis(2,1-ethanediylimino(3-oxo-3,1-propanediyl)))bis(2- ,4-dihydroxy-3,3-dimethyl-
57. Butyramide, N,n'-(dithiobis(ethyleneiminocarbonylethylene))bis(2,4-dihydroxy-3,3-dimethyl-, D-(+)-
58. N,n'-(dithiobis(2,1-ethanediylimino(3-oxo-3,1-propanediyl)))bis(2- ,4-dihydroxy-3,3-dimethylbutanamide
59. Smr001825140
60. H10620
61. Q228762
62. D-bis(n-pantothenyl-2-aminoethyl)-disulphide
63. J-010433
64. (2r)-n-[3-[2-[2-[3-[[(2r)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyldisulfanyl]ethylamino]-3-oxo-propyl]-2,4-dihydroxy-3,3-dimethyl-butanamide
65. (2r,2'r)-n,n'-{disulfanediylbis[ethane-2,1-diylimino(3-oxopropane-3,1-diyl)]}bis(2,4-dihydroxy-3,3-dimethylbutanamide)
66. N,n'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethylbutanamide]
67. N-[2-[2-[2-[3-[(2,4-dihydroxy-3,3-dimethyl-butanoyl)amino]propanoylamino]ethyldisulfanyl]ethylcarbamoyl]ethyl]-2,4-dihydroxy-3,3-dimethyl-butanamide
Molecular Weight | 554.7 g/mol |
---|---|
Molecular Formula | C22H42N4O8S2 |
XLogP3 | -2.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 19 |
Exact Mass | 554.24440666 g/mol |
Monoisotopic Mass | 554.24440666 g/mol |
Topological Polar Surface Area | 248 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 652 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A11 - Vitamins
A11H - Other plain vitamin preparations
A11HA - Other plain vitamin preparations
A11HA32 - Pantethine
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : Stevia is used as a sweetening agent in the production of oral dosage forms such as tablets.
Dosage Form : Solution
Grade : Oral
Application : Thickeners and Stabilizers
Excipient Details : Tapioca is used as a thickening agent and stabilizer in pharmaceutical liquid dosage form production.
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?